3′-Azido-3′-deoxythymidine inhibits erythroid-specific transcription factors in human erythroid K562 leukemia cells

European Journal of Haematology

Volumn 56, Issue 1-2, 1996, Pages 62-67

  Bridges, E G ^a,c   Trentesaux, C ^b   Lahlil, R ^b   Spiga, M G ^a   Jeannesson, P ^b   Sommadossi, J P ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AZT; GATA 1; Globin gene; NFE 2

Indexed keywords

BUTYRIC ACID; TRANSCRIPTION FACTOR; ZALCITABINE; ZIDOVUDINE;

ARTICLE; CELL DIFFERENTIATION; CELL STRAIN K 562; CONTROLLED STUDY; ERYTHROID CELL; GENETIC TRANSCRIPTION; GLOBIN GENE; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROMOTER REGION;

ANTIVIRAL AGENTS; BASE SEQUENCE; BINDING SITES; BUTYRIC ACID; BUTYRIC ACIDS; CELL LINE; CELL NUCLEUS; CONSENSUS SEQUENCE; DNA-BINDING PROTEINS; ERYTHROID-SPECIFIC DNA-BINDING FACTORS; GATA1 TRANSCRIPTION FACTOR; GLOBINS; HEMOGLOBINS; HOST CELL FACTOR C1; HUMANS; HYDROXYMETHYLBILANE SYNTHASE; LEUKEMIA, ERYTHROBLASTIC, ACUTE; NUCLEAR PROTEINS; OCTAMER TRANSCRIPTION FACTOR-1; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; ZALCITABINE; ZIDOVUDINE;

EID: 0029865226     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1996.tb00296.x     Document Type: Article

References (28)

1. RICHMANN DD, FISCHL MA, GRIECO MH, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind placebo-controlled trial. N Engl J Med 1987: 317: 192-197.
2. SOMMADOSSI JP, CARLISLE R. Toxicity of 3′-azido-3′-deoxythymidine and 9-(1,3-dihydroxy-2-propoxymethyl-guanine) from normal human hematopoietic progenitor cells in vitro. Antimicrob Agents Chemother 1987: 31: 452-454.
3. SOMMADOSSI JP, CARLISLE R, ZHOU Z. Cellular pharmacology of 3′-azido-3′-deoxythimidine with evidence of incorporation into DNA of human bone marrow cells. Mol Pharmacol 1989: 36: 9-14.
4. WEIDNER DA, SOMMADOSSI JP. 3′-azido-3′-deoxythymidine inhibits globin gene transcription in butyric acid-induced K562 human leukemia cells. Mol Pharmacol 1990: 38: 797-804.
5. CIOE L, MCNAB A, HUBBELL HR, MEO P, CURTIS P, ROVERA G. Differential expression of the globin gene in K562 cells induced to differentiate by hemin or butyric acid. Cancer Res 1981: 41: 237-243.
6. BROGGINI M, PONTI M, OTTOLENGHI S, D'INCALCI M, MONGELLI N, MANTOVANI R. Distamycins inhibit the binding of OTF-1 and NFE-1 transfactors to their conserved DNA elements. Nucleic Acids Res 1989: 17: 1051-1059.
7. MANTOVANI R, MALGARETTI N, NICOLIS S, RONCHI A, GIGLIONI B, OTTOLENGHI S. The effects of HPFH mutations in the human γ-globin promoter on binding of ubiquitous and erythroid specific nuclear factors. Nucleic Acids Res 1988: 16: 7783-7797.
8. MIGNOTTE V, ELEOUET JF, RAICH N, ROMEO PH. Cis-and trans-acting elements involved in the regulation of the erythroid promoter of the human porphobilinogen deaminase gene. Proc Natl Acad Sci USA 1989: 86: 6548-6552.
9. SCHREIBER E, MATTHIAS P, MULLER MM, SCHAFFNER W. Rapid detection of octamer binding proteins with "mini-extracts", prepared from a small number of cells. Nucleic Acids Res 1989: 17: 6419.
10. TRENTESAUX C, NGO NYOUNG M, ARIES A, et al. Increased expression of GATA-1 and NFE-2 erythroid-specific transcription factors during aclacinomycin-mediated differentiation of human erythroleukemic cells. Leukemia 1993: 7: 452-457.
11. MANTAVONI R, MALGARETTI N, GIGLIONI B, et al. A protein factor binding to an octamer motif in the γ-globin promoter disappears upon induction of differentiation and hemoglobin synthesis in K562 cells. Nucleic Acids Res 1987: 15: 9349-9364.
12. CHOMCYNSKI P, SACCHI N. Single step method of RNA isolation by acid guanidium thiocyanate-phenol chloroform extraction. Anal Biochem 1987: 162: 156-158.
13. VAZQUEZ-PADUA MA, STARNES MC, CHENG YC. Incorporation of 3′-azido-3′-deoxythymidine into cellular DNA and its removal in a human leukemic cell line. Cancer Commun 1990: 2: 55-62.
14. AVRAMIS VI, MARKSON W, JACKSON RL, GOMPERTS E. Biochemical pharmacology of zidovudine in human T-lymphoblastoid cells (CEM). AIDS 1989: 3: 417-422.
15. WEIDNER DA, BRIDGES EG, CRETTON EM, SOMMADOSSI JP. Comparative effects of 3′-azido-3′-deoxythymidine and its metabolite, 3′-amino-3′-deoxythymidine, on hemoglobin synthesis in K562 human leukemia cells. Mol Pharmacol 1991: 41: 252-258.
16. ORKIN SH. Globin gene regulation and switching: circa 1990. Cell 1990: 63: 665.
17. DALYOT N, FIBACH E, RONCHI A, RACHMILEWITZ E, OTTOLENGHI S, OPPENHEIM A. Erythropoietin triggers a burst of GATA-1 in normal human erythroid cells differentiating in tissue culture. Nucleic Acids Res 1993: 21: 4031-4037.
18. ORKIN SH. GATA-binding transcription factor in hematopoietic cells. Blood 1992: 80: 575-581.
19. FLETCHER C, HEINTZ N, ROEDER RG. Purification and characterization of OTF-1, a transcription factor regulating cell cycle expression of a human histone H2b gene. Cell 1987: 51: 773-781.
20. SCHUMACHER A, NORDHEIM A. Progress towards a molecular understanding of cyclosporin A-mediated immunosuppression. Clin Invest 1992: 70: 773-779.
21. BRACH MA, KHARBANDA SM, HERRMANN F, KUFE DW. Activation of the transcription factor κB in human KG-1 myeloid leukemia cells treated with 1-β-D-arabonfuranosyl-cytosine. Mol Pharm 1991: 41: 60-63.
22. HASCHEK WM, WEIGEL RM, SCHERBA G, et al. Zidovudine toxicity to cats infected with feline leukemia virus. Fundam Appl Toxicol 1990: 14: 764-775.
23. CHOW FPR, SUTTON PA, HAMBURGER AW. Sensitivity of erythroid progenitor colonies to erythropoietin in azidothymidine treated immunodeficient mice. Br J Haematol 1991: 77: 139-144.
24. GOGU SR, MALTER JS, AGRAWAL KC. Zidovudine-induced blockade of the expression and function of the erythropoietin receptor. Biochem Pharmacol 1992: 44: 1009-1012.
25. NICOLIS S, BERTINI C, RONCHI A, et al. An erythroid specific enhancer upstream to the gene encoding the cell-type specific transcription factor GATA-1. Nucleic Acids Res 1991: 19: 5285-5291.
26. MARTIN DIK, TSAI SF, ORKIN SH. Increased γ-globin expression in a nondeletion HPFH mediated by an erythroid-specific DNA-binding factor. Nature 1989: 338: 435-438.
27. NICOLIS S, RONCHI A, MALGARETTI N, MANTOVANI R, GIGLIONI B, OTTOLENGHI S. Increased erythroid-specific expression of a mutated HPFH g-globin promoter requires the erythroid factor GATA-1. Nucleic Acids Res 1989: 17: 5509-5516.
28. CHIBA T, IKAWA Y, TODOKORO K. GATA-1 transactivates erythropoietin receptor gene, and erythropoietin receptor-mediated signals enhance GATA-1 gene expression. Nucleic Acids Res 1991: 19: 3843-3848.